RHYTHM Biosciences Ltd Capital Reinvestment Ratio

Latest as of December 2024: 0.00x

RHYTHM Biosciences Ltd capital reinvestment ratio. RHYTHM Biosciences Ltd (RHY) has a Capital Reinvestment Ratio of 0.00x as of December 2024, meaning it reinvests 0% of its operating cash flow (AU$970.03K) in capital expenditures (AU$5.00). Check how aggressively does RHYTHM Biosciences Ltd reinvest cash to assess the company's total reinvestment commitment from operating cash flow.

Capital Reinvestment Ratio

0.00x

Capex / Operating Cash Flow

Operating Cash Flow

AU$970.03K

AUD

Capital Expenditures

AU$5.00

AUD

Data as of

Dec 2024

Most recent filing

RHYTHM Biosciences Ltd Capital Reinvestment Ratio by Year (None–None)

RHYTHM Biosciences Ltd capital reinvestment ratio by year from None to None. For the full cash flow conversion analysis, see RHYTHM Biosciences Ltd cash flow conversion.

Year	Reinvestment Ratio	Operating CF (AUD)	Capital Expenditures	YoY Change

Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow